These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 10334257)
1. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Albrecht T; Blomley MJ; Cosgrove DO; Taylor-Robinson SD; Jayaram V; Eckersley R; Urbank A; Butler-Barnes J; Patel N Lancet; 1999 May; 353(9164):1579-83. PubMed ID: 10334257 [TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. Ridolfi F; Abbattista T; Marini F; Vedovelli A; Quagliarini P; Busilacchi P; Brunelli E Dig Liver Dis; 2007 Oct; 39(10):929-35. PubMed ID: 17669702 [TBL] [Abstract][Full Text] [Related]
3. Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis: A 10-Year Single-Center Experience With Contrast-Enhanced Sonography. Abbattista T; Ridolfi F; Consalvo GT; Brunelli E J Ultrasound Med; 2016 Oct; 35(10):2121-8. PubMed ID: 27503751 [TBL] [Abstract][Full Text] [Related]
4. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694 [TBL] [Abstract][Full Text] [Related]
5. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Lim AK; Taylor-Robinson SD; Patel N; Eckersley RJ; Goldin RD; Hamilton G; Foster GR; Thomas HC; Cosgrove DO; Blomley MJ Gut; 2005 Jan; 54(1):128-33. PubMed ID: 15591518 [TBL] [Abstract][Full Text] [Related]
6. Hepatic transit time of ultrasound contrast in biopsy characterized liver disease. Pedersen JF; Larsen VA; Bytzer P; Madsen LG; Hamberg O Acta Radiol; 2005 Oct; 46(6):557-60. PubMed ID: 16334835 [TBL] [Abstract][Full Text] [Related]
7. Liver cirrhosis: evaluation of haemodynamic changes using an ultrasound contrast agent. Giuseppetti GM; Argalia G; Abbattista T Eur J Radiol; 2004 Jul; 51(1):27-33. PubMed ID: 15186881 [TBL] [Abstract][Full Text] [Related]
8. Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging. Bang N; Nielsen MB; Rasmussen AN; Osterhammel PA; Pedersen JF Br J Radiol; 2001 Aug; 74(884):752-5. PubMed ID: 11511501 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography. Abbattista T; Ridolfi F; Ciabattoni E; Marini F; Bendia E; Brunelli E; Busilacchi P Radiol Med; 2008 Sep; 113(6):860-74. PubMed ID: 18587531 [TBL] [Abstract][Full Text] [Related]
10. Intrahepatic circulatory time analysis of an ultrasound contrast agent in liver cirrhosis. Hirota M; Kaneko T; Sugimoto H; Kure S; Inoue S; Takeda S; Nakao A Liver Int; 2005 Apr; 25(2):337-42. PubMed ID: 15780059 [TBL] [Abstract][Full Text] [Related]
11. Hepatic vein transit time of SonoVue: a comparative study with Levovist. Lim AK; Patel N; Eckersley RJ; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; Blomley MJ Radiology; 2006 Jul; 240(1):130-5. PubMed ID: 16720867 [TBL] [Abstract][Full Text] [Related]
13. Obliteration of gastric varices improves the arrival time of ultrasound contrast agents in hepatic artery and vein. Furuichi Y; Moriyasu F; Sugimoto K; Taira J; Sano T; Miyata Y; Sofuni A; Itoi T; Nakamura I; Imai Y J Gastroenterol Hepatol; 2013 Sep; 28(9):1526-31. PubMed ID: 23611144 [TBL] [Abstract][Full Text] [Related]
14. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study. Blomley MJ; Lim AK; Harvey CJ; Patel N; Eckersley RJ; Basilico R; Heckemann R; Urbank A; Cosgrove DO; Taylor-Robinson SD Gut; 2003 Aug; 52(8):1188-93. PubMed ID: 12865280 [TBL] [Abstract][Full Text] [Related]
15. Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension. Luisa S; Vitale G; Sorbo AR; Maurizio P; Lodovico RG J Ultrasound; 2017 Mar; 20(1):43-52. PubMed ID: 28298943 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and morphologic changes of peripheral hepatic vasculature in cirrhotic liver disease: a preliminary study using contrast-enhanced coded phase inversion harmonic ultrasonography. Zheng RQ; Zhang B; Kudo M; Sakaguchi Y World J Gastroenterol; 2005 Oct; 11(40):6348-53. PubMed ID: 16419164 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of hepatic vein arrival time performed with contrast-enhanced ultrasonography for HCV liver cirrhosis. Makhlouf NA; Moustafa EF; Hassany SM Arab J Gastroenterol; 2022 Aug; 23(3):195-200. PubMed ID: 35688684 [TBL] [Abstract][Full Text] [Related]
18. Assessment of hepatic fibrosis by analysis of the dynamic behaviour of microbubbles during contrast ultrasonography. Ishibashi H; Maruyama H; Takahashi M; Fujiwara K; Imazeki F; Yokosuka O Liver Int; 2010 Oct; 30(9):1355-63. PubMed ID: 20704652 [TBL] [Abstract][Full Text] [Related]
19. Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study. Searle J; Mendelson R; Zelesco M; Sanford J; Cheng W; McKinstry C; Ramsay D J Med Imaging Radiat Oncol; 2008 Apr; 52(2):130-3. PubMed ID: 18373803 [TBL] [Abstract][Full Text] [Related]
20. Gray and color Doppler ultrasonography in differentiation between chronic viral hepatitis and compensated early stage cirrhosis. Iliopoulos P; Vlychou M; Margaritis V; Tsamis I; Tepetes K; Petsas T; Karatza C J Gastrointestin Liver Dis; 2007 Sep; 16(3):279-86. PubMed ID: 17925922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]